A phase 2, open label, clinical trial of pre-surgical and adjuvant treatment of recurrent glioblastoma with tremelimumab and durvalumab alone and in combination

Journal of Neuro-Oncology 2026

View at publisher
Authors: Karan Dixit, Priya Kumthekar, Rimas Vincas Lukas, Andrew Williams, Matthew C. Tate, James P. Chandler, Pouya Jamshidi, Irene Helenowski, Hui Zhang, Orin G. Bloch, Jeffrey J. Raizer
DOI: 10.1007/s11060-026-05446-1
Cited by: 0
References: 24

Fields of Study & Subjects

Glioma Diagnosis and Treatment Cancer Immunotherapy and Biomarkers Cancer survivorship and care

Publication details

Journal / source
Journal of Neuro-Oncology
Volume
176
Issue
3
Pages
185–185
Publication date
28 January 2026
Language
EN